Our continuously-evolving nferX software has the potential to transform the way scientists generate and vet hypotheses to tackle some of healthcare’s biggest challenges. As part of our strategic collaborations with some of the leading biopharmaceutical companies, we are providing access to the nferX software to select alpha users at those biopharma partners.

Benefits:

Literature Synthesis

Natural language is at the heart of we learn and communicate concepts and ideas. However, our capacity to read and process this wealth of information cannot keep up with the explosion of biomedical literature.

Molecular Analytics

By leveraging the nferX technology, we have been able to process and analyze hundreds of thousands of samples and their annotations in a systematic, automated manner.

Real World Evidence

nference has access to both public and proprietary real world datasets. By triangulating real world evidence with our molecular analytics and knowledge synthesis capabilities, nference is able to infer causal genotype-phenotype relationships.

linkedin Page of the Product

Website of the Product